The Expression of CXCL10/CXCR3 and Effect of the Axis on the Function of T Lymphocyte Involved in Oral Lichen Planus.
CXCL10
CXCR3
chemokine
oral lichen planus
Journal
Inflammation
ISSN: 1573-2576
Titre abrégé: Inflammation
Pays: United States
ID NLM: 7600105
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
pubmed:
24
11
2018
medline:
18
12
2019
entrez:
24
11
2018
Statut:
ppublish
Résumé
The etiology of oral lichen planus (OLP) is still not clear. The purpose of this study was to explore the role of CXC chemokine receptor 3(CXCR3) and its ligand CXC motif chemokine 10(CXCL10) in the pathogenesis of OLP. We examined the expression of CXCR3 and CXCL10 in OLP patients and healthy controls by quantitative real-time PCR, Western blotting, ELISAs, and immunohistochemistry, respectively. Moreover, we detected the effects of CXCL10/CXCR3 axis on T lymphocyte migration, proliferation and apoptosis by Transwell assays, CCK8 assays, and flow cytometry. We found that the expression of CXCR3 and CXCL10 was significantly increased in OLP patients. In addition, T lymphocyte migration rate of CXCL10 stimulation group was significantly higher than that of control and CXCR3 antagonist groups. After antagonizing CXCR3, the migration ability of T lymphocytes was significantly decreased, and regardless of whether CXCL10 was added in the upper chamber culture medium, the number of migrating cells was similar. The addition of CXCL10 stimulant could stimulate the proliferation of T lymphocytes, but there was no significant difference compared with control group. After antagonizing CXCR3, the proliferation rate of T lymphocytes was significantly reduced. However, there were no significant differences in the apoptosis rates of T lymphocytes between CXCL10 stimulation group, antagonist CXCR3 group, and control group. Due to the change of expression in CXCR3 and CXCL10, and its interaction in mediating the directional migration of peripheral blood T lymphocytes, affecting the proliferation of T lymphocytes, it suggests that CXCL10/CXCR3 axis may be related to the immune mechanism of OLP.
Identifiants
pubmed: 30467622
doi: 10.1007/s10753-018-0934-0
pii: 10.1007/s10753-018-0934-0
doi:
Substances chimiques
CXCR3 protein, human
0
Chemokine CXCL10
0
Receptors, CXCR3
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
799-810Subventions
Organisme : National Natural Science Foundation of China
ID : 81470748
Références
Biomed Res Int. 2014;2014:893106
pubmed: 24868552
Neuropathol Appl Neurobiol. 2010 Aug;36(5):368-87
pubmed: 20487305
Iran J Immunol. 2011 Mar;8(1):1-10
pubmed: 21427490
Int J Clin Exp Pathol. 2015 Nov 01;8(11):14542-8
pubmed: 26823775
J Pathol. 2001 Aug;194(4):398-405
pubmed: 11523046
Neurol Neurochir Pol. 2016;50(3):155-62
pubmed: 27154441
Oral Oncol. 2010 Jun;46(6):423-5
pubmed: 20308005
Adv Med Sci. 2015 Sep;60(2):349-54
pubmed: 26318079
Am J Pathol. 2017 Feb;187(2):352-365
pubmed: 27960090
Clin Sci (Lond). 2016 Apr 1;130(7):463-78
pubmed: 26888559
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Aug;110(2):188-95
pubmed: 20659697
Inflammation. 2015 Oct;38(5):1874-9
pubmed: 25825144
J Virol. 2011 Jul;85(13):6136-47
pubmed: 21507985
Cytokine Growth Factor Rev. 2015 Jun;26(3):311-27
pubmed: 25498524
Immunopharmacol Immunotoxicol. 2011 Mar;33(1):11-20
pubmed: 20604639
J Neurol. 2002 Jun;249(6):723-9
pubmed: 12111306
Expert Rev Clin Pharmacol. 2016 Jun;9(6):853-61
pubmed: 26900630
Diabetes. 2013 Jul;62(7):2492-9
pubmed: 23434930
Arthritis Res Ther. 2003;5(5):R241-52
pubmed: 12932287
Cytokine. 2013 Apr;62(1):141-5
pubmed: 23490419
Clin Cancer Res. 2010 Nov 15;16(22):5458-68
pubmed: 20889916
Autoimmun Rev. 2014 Mar;13(3):272-80
pubmed: 24189283
Rev Diabet Stud. 2009;6(2):81-4
pubmed: 19806237
Med Hypotheses. 2017 Jul;104:40-44
pubmed: 28673588
J Oral Pathol Med. 2003 Oct;32(9):507-12
pubmed: 12969224
J Immunol. 2006 May 15;176(10):6235-44
pubmed: 16670334
Clin Exp Immunol. 2007 Jun;148(3):515-9
pubmed: 17374135
J Oral Pathol Med. 2008 Sep;37(8):447-53
pubmed: 18624932
J Clin Diagn Res. 2016 Feb;10(2):ZE10-5
pubmed: 27042598
BMJ Open. 2018 Oct 8;8(10):e024083
pubmed: 30297352
Mod Pathol. 2010 Feb;23(2):213-24
pubmed: 19915524
PLoS One. 2014 Feb 20;9(2):e89068
pubmed: 24586509
Pediatr Neurol. 2013 Dec;49(6):451-457.e1
pubmed: 24080276
Cytokine Growth Factor Rev. 2014 Feb;25(1):57-65
pubmed: 24529741
Biomed Pharmacother. 2016 Aug;82:479-88
pubmed: 27470388
Cytokine. 2012 Aug;59(2):433-41
pubmed: 22652417